2017
DOI: 10.1097/shk.0000000000000811
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac Troponin Release is Associated with Biomarkers of Inflammation and Ventricular Dilatation During Critical Illness

Abstract: Introduction:Troponin release is common during critical illness. We hypothesized that there was an association between cardiac troponin T (cTnT) and biomarkers of systemic inflammation and ventricular dilatation.Methods:In an observational prospective cohort study, we enrolled consecutive adult patients admitted for noncardiac reasons to the intensive care unit (ICU) in two tertiary care centers. We measured cTnT, C-reactive protein (CRP), interleukin-6 (IL-6), procalcitonin (PCT), and N-terminal pro brain nat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
26
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 43 publications
(28 citation statements)
references
References 43 publications
1
26
1
Order By: Relevance
“…In line with former findings, inflammatory states are independently associated with higher cTnT, as described before . In this current study CRP levels above the URL (> 5 mg/L URL) were associated with a 3‐fold increased risk for elevated cTnT levels.…”
Section: Discussionsupporting
confidence: 92%
“…In line with former findings, inflammatory states are independently associated with higher cTnT, as described before . In this current study CRP levels above the URL (> 5 mg/L URL) were associated with a 3‐fold increased risk for elevated cTnT levels.…”
Section: Discussionsupporting
confidence: 92%
“…Some of this variability may be due to the fact that cardiac biomarker concentrations above the reference range are common in sepsis, with prevalence as high as 84% for cTnT [ 77 ], 98% for NT-proBNP [ 75 ], and 100% for hsTnT [ 70 ]. Existing data are limited by residual confounding from clinical contributors, including age, disease severity, comorbidities (including flow-limiting CAD), and treatment.…”
Section: Pathophysiologymentioning
confidence: 99%
“…3,4 Acute events in cardiovascular diseases have been successfully diagnosed by monitoring established biochemical markers, such as creatine kinase MB, myoglobin, and cardiac troponins I and T. [2][3][4][5][6] Cardiac troponin T (cTnT) is widely used as a specic biomarker for myocardial tissue and is considered as the "gold standard" for the serological diagnosis and prognosis of AMI due to its high sensitivity and specicity. [6][7][8] During myocardial infarction, cTnT is immediately released into the bloodstream. Therefore, the rapid and accurate monitoring of this biomarker could improve the quality of patient care.…”
Section: Introductionmentioning
confidence: 99%